biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by unclepiemanon Sep 27, 2013 1:36pm

301 Views

Post# 21773571

Perfect time

This would be the perfect time for the company to start doing supporting NR leading up to the event with perhaps information on how they may be on track, existing/new interests of collaborations, growth plans and such. That way its not a jump from $x to $xx with all hell breaking loose, and lessen the risk of "IT DID NOT WORK! Sorry" ...

I've held for years and even when i thought it was stupid... i held. I just dont want No noise at all until the data release... makes things kinda uneasy

next 3weeks going to be interesting ... good or bad

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property